Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer.
暂无分享，去创建一个
T. Honjo | N. Matsumura | T. Baba | M. Minami | S. Morita | I. Konishi | M. Yokode | T. Murayama | S. Chikuma | K. Yamaguchi | M. Mandai | J. Hamanishi | A. Kawaguchi | Akira Shimizu | M. Kanai | T. Ikeda | Y. Mori | S. Matsumoto | Akihiko Ueda | K. Abiko